相关实验视频

Updated: May 23, 2025

Intrathecal Delivery of Antisense Oligonucleotides in the Rat Central Nervous System

Intrathecal Delivery of Antisense Oligonucleotides in the Rat Central Nervous System

Published on: October 29, 2019

对遗传和表型特征的系统分析揭示了对三分之一的神经发育障碍的反意义寡核酸治疗潜力

Kim N Wijnant^1,2,3, Nael Nadif Kasri^1,2, Lisenka E L M Vissers^4,5

¹Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.

Genome medicine

|May 21, 2025

概括

反感性寡核酸 (AON) 显示出治疗神经发育障碍 (NDD) 的前景. 这项研究确定了711个适合AON治疗的NDD,可能使18%受影响的患者受益.

科学领域:

遗传学和分子生物学
神经科学是一个神经科学.
药理学药理学是指药理学的学科.

背景情况:

神经发育障碍 (NDD) 存在重大治疗挑战.
反意义寡核酸 (AONs) 正在成为NDD的有前途的治疗策略.
对NDD的AON治疗适用性受到遗传和表型因素的影响.

研究的目的:

系统地评估NDD对AON治疗的适用性.
估计AONs对NDDs的整体治疗潜力.
识别已研究良好的和较少研究的可向的NDD.

主要方法:

创建并评估了七个AON战略的NDD数据集.
评估疾病基因特性,包括调控因素和病原性变异效应.
检查了与疾病相关的表型特征,以确定AON的适用性.

主要成果:

确定了711个NDD (38%),其特征有利于至少一个AON策略.
预测有18%的NDD患者可能会从AON治疗中受益.
基于可准特征的系统评估的NDD和AON策略.

结论:

AON疗法对NDD治疗的潜力比以前被认为的更大.
这项研究支持AONs作为NDD的可行的治疗选择.
调查结果有助于明智地选择针对特定NDD的AON疗法.

关键词:

AON治疗的适用性 AON治疗的适用性反意义的寡核化物.神经发育障碍神经发育障碍评估可针对性的评估.

更多相关视频

Direct Intraventricular Delivery of Drugs to the Rodent Central Nervous System

Direct Intraventricular Delivery of Drugs to the Rodent Central Nervous System

Published on: May 12, 2013

Evaluation of Exon Inclusion Induced by Splice Switching Antisense Oligonucleotides in SMA Patient Fibroblasts

Evaluation of Exon Inclusion Induced by Splice Switching Antisense Oligonucleotides in SMA Patient Fibroblasts

Published on: May 11, 2018

相关概念视频

siRNA - Small Interfering RNAs

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...

Experimental RNAi

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...